Summary

The global Rapid Influenza Diagnostic Testing (RIDT) market is steadily advancing as healthcare providers emphasize the importance of timely detection and management of infectious diseases. Influenza remains a persistent global health concern, driving the need for rapid and reliable diagnostic solutions across clinical settings. The market is valued at USD 1.5 billion in 2026 and is projected to reach USD 2.2 billion by 2033, registering a compound annual growth rate (CAGR) of 5.40% over the forecast period. Increasing demand for quick diagnosis, improved patient outcomes, and enhanced infection control practices continues to support market growth.

Market Insights

Rapid influenza diagnostic tests play a crucial role in identifying influenza viruses by detecting viral antigens in respiratory samples within a short turnaround time. These tests have become essential in managing seasonal outbreaks, enabling clinicians to make faster treatment decisions. The market is witnessing continuous innovation, with advancements in digital and molecular diagnostic technologies significantly improving test accuracy and efficiency.

Growing awareness regarding influenza-related complications and the importance of early diagnosis is encouraging the adoption of RIDTs worldwide. The expansion of point-of-care testing has further strengthened market penetration, particularly in decentralized healthcare environments. Healthcare professionals are increasingly utilizing these tests to optimize treatment pathways and reduce unnecessary medication use.

Drivers

The rising incidence of influenza infections globally remains a key driver for the RIDT market. Seasonal flu outbreaks continue to place a significant burden on healthcare systems, highlighting the need for efficient diagnostic tools. Rapid testing allows for immediate clinical decisions, helping reduce disease transmission and improve patient management.

Technological progress is another major factor contributing to market expansion. The development of digital RIDTs and molecular-based diagnostic methods has enhanced sensitivity and specificity, addressing limitations associated with traditional testing approaches. These innovations are increasing the reliability and adoption of rapid testing solutions.

Additionally, the growing focus on point-of-care diagnostics is accelerating market growth. RIDTs offer convenience, speed, and ease of use, making them suitable for a wide range of healthcare settings. Supportive government initiatives and public health campaigns aimed at strengthening disease surveillance are further boosting demand.

Business Opportunity

The RIDT market offers substantial growth opportunities for industry participants. Emerging economies across Asia Pacific, Latin America, and the Middle East & Africa are witnessing increasing investments in healthcare infrastructure, creating favorable conditions for market expansion. Companies can leverage these opportunities by introducing affordable and accessible diagnostic solutions tailored to regional requirements.

The integration of digital technologies into diagnostic platforms is opening new avenues for innovation. Digital RIDTs with connectivity features enable real-time data sharing and improved disease tracking, which is particularly valuable for public health monitoring. This trend is expected to gain momentum in the coming years.

Strategic collaborations between diagnostic manufacturers, healthcare providers, and research organizations are also expected to drive product development and market growth. Such partnerships can facilitate the introduction of advanced testing solutions with enhanced capabilities.

Region Analysis

North America continues to dominate the RIDT market, supported by advanced healthcare infrastructure, high awareness levels, and strong regulatory frameworks. The presence of leading diagnostic companies and continuous technological advancements further strengthen the region’s leadership position.

Europe represents a mature market with significant adoption of rapid diagnostic technologies. Government initiatives focused on disease prevention and early diagnosis are contributing to steady market growth across the region.

Asia Pacific is anticipated to emerge as the fastest-growing market during the forecast period. Rising healthcare expenditure, increasing population, and growing awareness of infectious diseases are driving demand for rapid diagnostic solutions. Countries such as China, India, and Japan are investing in healthcare development, supporting market expansion.

Latin America and the Middle East & Africa are also experiencing gradual growth, driven by improving healthcare access and increasing focus on disease detection. However, economic constraints and limited resources may pose challenges in certain areas.

Key Players

• Abbott Laboratories

• F. Hoffmann-La Roche Ltd. (Roche Diagnostics)

• Thermo Fisher Scientific Inc.

• QuidelOrtho Corporation (Quidel Corporation)

• Becton, Dickinson and Company (BD)

• DiaSorin S.p.A.

• Meridian Bioscience, Inc.

• Sekisui Diagnostics

• Hologic, Inc.

• Bio-Rad Laboratories, Inc.

• Siemens Healthineers AG

• Luminex Corporation (now part of DiaSorin)

• Analytik Jena AG (Endress+Hauser Group)

• Princeton BioMeditech Corporation

• Coris BioConcept

Segmentation

By Product Type

• Conventional RIDTs

• Digital RIDTs

By Test Type

• Influenza A Tests

• Influenza B Tests

• Influenza A+B Combination Tests

By Technology

• Immunochromatographic Assays

• Lateral Flow Assays

• Molecular Diagnostics (PCR & NAAT)

• Immunofluorescence Assays

By End User

• Hospitals

• Diagnostic Laboratories

• Clinics

• Research Institutes

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Rapid Influenza Diagnostic Testing (RIDT) Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, 2020-2033
3.1. Global Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
3.1.1. Conventional RIDTs
3.1.2. Digital RIDTs
3.2. Global Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
3.2.1. Influenza A Tests
3.2.2. Influenza B Tests
3.2.3. Influenza A+B Combination Tests
3.3. Global Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, Value (US$ Bn), 2020-2033
3.3.1. Immunochromatographic Assays
3.3.2. Lateral Flow Assays
3.3.3. Molecular Diagnostics (PCR & NAAT)
3.3.4. Immunofluorescence Assays
3.4. Global Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, Value (US$ Bn), 2020-2033
3.4.1. Hospitals
3.4.2. Diagnostic Laboratories
3.4.3. Clinics
3.4.4. Research Institutes
3.5. Global Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.5.1. North America
3.5.2. Europe
3.5.3. Asia Pacific
3.5.4. Latin America
3.5.5. Middle East & Africa
4. North America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, 2020-2033
4.1. North America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
4.1.1. Conventional RIDTs
4.1.2. Digital RIDTs
4.2. North America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
4.2.1. Influenza A Tests
4.2.2. Influenza B Tests
4.2.3. Influenza A+B Combination Tests
4.3. North America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, Value (US$ Bn), 2020-2033
4.3.1. Immunochromatographic Assays
4.3.2. Lateral Flow Assays
4.3.3. Molecular Diagnostics (PCR & NAAT)
4.3.4. Immunofluorescence Assays
4.4. North America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, Value (US$ Bn), 2020-2033
4.4.1. Hospitals
4.4.2. Diagnostic Laboratories
4.4.3. Clinics
4.4.4. Research Institutes
4.5. North America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.5.1. U.S. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
4.5.2. U.S. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
4.5.3. U.S. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
4.5.4. U.S. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
4.5.5. Canada Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
4.5.6. Canada Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
4.5.7. Canada Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
4.5.8. Canada Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, 2020-2033
5.1. Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
5.1.1. Conventional RIDTs
5.1.2. Digital RIDTs
5.2. Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
5.2.1. Influenza A Tests
5.2.2. Influenza B Tests
5.2.3. Influenza A+B Combination Tests
5.3. Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, Value (US$ Bn), 2020-2033
5.3.1. Immunochromatographic Assays
5.3.2. Lateral Flow Assays
5.3.3. Molecular Diagnostics (PCR & NAAT)
5.3.4. Immunofluorescence Assays
5.4. Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, Value (US$ Bn), 2020-2033
5.4.1. Hospitals
5.4.2. Diagnostic Laboratories
5.4.3. Clinics
5.4.4. Research Institutes
5.5. Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.5.1. Germany Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.2. Germany Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.3. Germany Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.4. Germany Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.5.5. Italy Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.6. Italy Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.7. Italy Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.8. Italy Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.5.9. France Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.10. France Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.11. France Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.12. France Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.5.13. U.K. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.14. U.K. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.15. U.K. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.16. U.K. Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.5.17. Spain Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.18. Spain Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.19. Spain Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.20. Spain Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.5.21. Russia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.22. Russia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.23. Russia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.24. Russia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.5.25. Rest of Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
5.5.26. Rest of Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
5.5.27. Rest of Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
5.5.28. Rest of Europe Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, 2020-2033
6.1. Asia Pacific Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
6.1.1. Conventional RIDTs
6.1.2. Digital RIDTs
6.2. Asia Pacific Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
6.2.1. Influenza A Tests
6.2.2. Influenza B Tests
6.2.3. Influenza A+B Combination Tests
6.3. Asia Pacific Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, Value (US$ Bn), 2020-2033
6.3.1. Immunochromatographic Assays
6.3.2. Lateral Flow Assays
6.3.3. Molecular Diagnostics (PCR & NAAT)
6.3.4. Immunofluorescence Assays
6.4. Asia Pacific Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, Value (US$ Bn), 2020-2033
6.4.1. Hospitals
6.4.2. Diagnostic Laboratories
6.4.3. Clinics
6.4.4. Research Institutes
6.5. Asia Pacific Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.5.1. China Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
6.5.2. China Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
6.5.3. China Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
6.5.4. China Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
6.5.5. Japan Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
6.5.6. Japan Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
6.5.7. Japan Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
6.5.8. Japan Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
6.5.9. South Korea Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
6.5.10. South Korea Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
6.5.11. South Korea Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
6.5.12. South Korea Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
6.5.13. India Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
6.5.14. India Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
6.5.15. India Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
6.5.16. India Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
6.5.17. Southeast Asia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
6.5.18. Southeast Asia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
6.5.19. Southeast Asia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
6.5.20. Southeast Asia Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
6.5.21. Rest of SAO Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
6.5.22. Rest of SAO Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
6.5.23. Rest of SAO Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
6.5.24. Rest of SAO Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, 2020-2033
7.1. Latin America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
7.1.1. Conventional RIDTs
7.1.2. Digital RIDTs
7.2. Latin America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
7.2.1. Influenza A Tests
7.2.2. Influenza B Tests
7.2.3. Influenza A+B Combination Tests
7.3. Latin America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, Value (US$ Bn), 2020-2033
7.3.1. Immunochromatographic Assays
7.3.2. Lateral Flow Assays
7.3.3. Molecular Diagnostics (PCR & NAAT)
7.3.4. Immunofluorescence Assays
7.4. Latin America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, Value (US$ Bn), 2020-2033
7.4.1. Hospitals
7.4.2. Diagnostic Laboratories
7.4.3. Clinics
7.4.4. Research Institutes
7.5. Latin America Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.5.1. Brazil Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
7.5.2. Brazil Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
7.5.3. Brazil Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
7.5.4. Brazil Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
7.5.5. Mexico Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
7.5.6. Mexico Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
7.5.7. Mexico Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
7.5.8. Mexico Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
7.5.9. Argentina Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
7.5.10. Argentina Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
7.5.11. Argentina Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
7.5.12. Argentina Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
7.5.13. Rest of LATAM Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
7.5.14. Rest of LATAM Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
7.5.15. Rest of LATAM Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
7.5.16. Rest of LATAM Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, 2020-2033
8.1. Middle East & Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
8.1.1. Conventional RIDTs
8.1.2. Digital RIDTs
8.2. Middle East & Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, Value (US$ Bn), 2020-2033
8.2.1. Influenza A Tests
8.2.2. Influenza B Tests
8.2.3. Influenza A+B Combination Tests
8.3. Middle East & Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, Value (US$ Bn), 2020-2033
8.3.1. Immunochromatographic Assays
8.3.2. Lateral Flow Assays
8.3.3. Molecular Diagnostics (PCR & NAAT)
8.3.4. Immunofluorescence Assays
8.4. Middle East & Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, Value (US$ Bn), 2020-2033
8.4.1. Hospitals
8.4.2. Diagnostic Laboratories
8.4.3. Clinics
8.4.4. Research Institutes
8.5. Middle East & Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.5.1. GCC Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
8.5.2. GCC Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
8.5.3. GCC Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
8.5.4. GCC Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
8.5.5. South Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
8.5.6. South Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
8.5.7. South Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
8.5.8. South Africa Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
8.5.9. Egypt Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
8.5.10. Egypt Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
8.5.11. Egypt Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
8.5.12. Egypt Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
8.5.13. Nigeria Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
8.5.14. Nigeria Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
8.5.15. Nigeria Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
8.5.16. Nigeria Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
8.5.17. Rest of Middle East Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Product Type, 2020-2033
8.5.18. Rest of Middle East Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Test Type, 2020-2033
8.5.19. Rest of Middle East Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by Technology, 2020-2033
8.5.20. Rest of Middle East Rapid Influenza Diagnostic Testing (RIDT) Market Outlook, by End User, 2020-2033
8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. F. Hoffmann-La Roche Ltd. (Roche Diagnostics)
9.4.3. Thermo Fisher Scientific Inc.
9.4.4. QuidelOrtho Corporation (Quidel Corporation)
9.4.5. Becton, Dickinson and Company (BD)
9.4.6. DiaSorin S.p.A.
9.4.7. Meridian Bioscience, Inc.
9.4.8. Sekisui Diagnostics
9.4.9. Hologic, Inc.
9.4.10. Bio-Rad Laboratories, Inc.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations